Empowering OTC Traders Through Education

Connect With OTC Blueprint HQ

Whether you’re new to OTC markets or continuing your trading journey, we’re here to support your learning experience with educational resources, insights, and community updates.

Get in Touch with Us

Frequently Asked Questions

Answers to common questions about OTC Blueprint HQ, our educational content, and how to connect with us.

You can reach us anytime via email at info@otcblueprinthq.com We aim to respond to all inquiries as quickly as possible during regular business hours.

Our support hours are Monday through Friday, 9:00 AM – 5:00 PM EST. We do our best to respond promptly to all questions and support requests.

You can subscribe by entering your email address in the newsletter section on our website. Subscribers receive educational updates, OTC market insights, new resources, and future platform announcements.

Our educational content can be found throughout the website, including the OTC Beginner Blueprint, Blog, Resources, and Education sections. We regularly publish content focused on OTC trading, share structure, filings, catalysts, and risk management.

No. OTC Blueprint HQ is an educational platform created to help traders better understand OTC markets. Nothing on this website should be considered financial, investment, legal, or tax advice.

Yes. You can follow OTC Blueprint HQ on our social media platforms for updates, educational content, and market discussions. Social links are available in the website footer.

Stay Updated with Our Insights

Join our newsletter to receive OTC market insights, educational resources, and platform updates directly to your inbox. We aim to equip you with the knowledge you need for OTC trading success.

By subscribing, you agree to our Terms & Conditions and Privacy Policy.

Connect With OTC Blueprint HQ

Follow OTC Blueprint HQ for educational content, OTC market insights, trading psychology, and platform updates.
For inquiries or support, feel free to contact us anytime.

Verified by MonsterInsights